Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 12.98
(-0.15%)
CNY 12.98
(-0.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 10.34 Billion CNY | 27.25% |
| 2022 | 8.12 Billion CNY | 4.37% |
| 2021 | 7.78 Billion CNY | 28.14% |
| 2020 | 6.07 Billion CNY | 23.41% |
| 2019 | 4.92 Billion CNY | 30.87% |
| 2018 | 3.76 Billion CNY | 36.38% |
| 2017 | 2.75 Billion CNY | 49.61% |
| 2016 | 1.84 Billion CNY | 25.06% |
| 2015 | 1.47 Billion CNY | 36.71% |
| 2014 | 1.07 Billion CNY | 18.42% |
| 2013 | 910.99 Million CNY | 23.5% |
| 2012 | 737.63 Million CNY | 1.71% |
| 2011 | 725.19 Million CNY | 48.75% |
| 2010 | 487.53 Million CNY | 40.81% |
| 2009 | 346.24 Million CNY | 42.26% |
| 2008 | 243.39 Million CNY | 37.43% |
| 2007 | 177.1 Million CNY | 79.4% |
| 2006 | 98.72 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.5 Billion CNY | 24.77% |
| 2024 Q2 | 2.64 Billion CNY | 5.53% |
| 2024 Q3 | 3.1 Billion CNY | 17.19% |
| 2023 FY | 10.34 Billion CNY | 27.25% |
| 2023 Q3 | 3.26 Billion CNY | 21.47% |
| 2023 Q4 | 2.01 Billion CNY | -38.36% |
| 2023 Q2 | 2.68 Billion CNY | 12.67% |
| 2023 Q1 | 2.38 Billion CNY | 76.08% |
| 2022 Q3 | 2.77 Billion CNY | 36.12% |
| 2022 FY | 8.12 Billion CNY | 4.37% |
| 2022 Q1 | 1.95 Billion CNY | 13.68% |
| 2022 Q2 | 2.03 Billion CNY | 4.12% |
| 2022 Q4 | 1.35 Billion CNY | -51.23% |
| 2021 Q3 | 2.48 Billion CNY | 29.4% |
| 2021 Q2 | 1.91 Billion CNY | 15.57% |
| 2021 Q1 | 1.66 Billion CNY | -16.82% |
| 2021 FY | 7.78 Billion CNY | 28.14% |
| 2021 Q4 | 1.72 Billion CNY | -30.63% |
| 2020 Q2 | 1.33 Billion CNY | 171.24% |
| 2020 Q3 | 2.26 Billion CNY | 69.87% |
| 2020 Q4 | 1.99 Billion CNY | -11.63% |
| 2020 FY | 6.07 Billion CNY | 23.41% |
| 2020 Q1 | 490.54 Million CNY | -58.51% |
| 2019 Q3 | 1.5 Billion CNY | 23.42% |
| 2019 Q1 | 1.01 Billion CNY | 22.2% |
| 2019 FY | 4.92 Billion CNY | 30.87% |
| 2019 Q4 | 1.18 Billion CNY | -21.42% |
| 2019 Q2 | 1.21 Billion CNY | 19.52% |
| 2018 Q1 | 780.06 Million CNY | 22.61% |
| 2018 Q3 | 1.12 Billion CNY | 10.43% |
| 2018 Q4 | 834.61 Million CNY | -26.0% |
| 2018 FY | 3.76 Billion CNY | 36.38% |
| 2018 Q2 | 1.02 Billion CNY | 30.92% |
| 2017 Q3 | 907.37 Million CNY | 31.77% |
| 2017 Q4 | 636.2 Million CNY | -29.88% |
| 2017 FY | 2.75 Billion CNY | 49.61% |
| 2017 Q1 | 527.56 Million CNY | 37.04% |
| 2017 Q2 | 688.62 Million CNY | 30.53% |
| 2016 FY | 1.84 Billion CNY | 25.06% |
| 2016 Q1 | 416.25 Million CNY | 36.63% |
| 2016 Q2 | 479.02 Million CNY | 15.08% |
| 2016 Q3 | 564.34 Million CNY | 17.81% |
| 2016 Q4 | 384.97 Million CNY | -31.78% |
| 2015 Q4 | 304.66 Million CNY | -38.13% |
| 2015 Q3 | 492.45 Million CNY | 26.1% |
| 2015 Q2 | 390.52 Million CNY | 35.94% |
| 2015 Q1 | 287.27 Million CNY | 28.8% |
| 2015 FY | 1.47 Billion CNY | 36.71% |
| 2014 Q2 | 275.04 Million CNY | 20.61% |
| 2014 FY | 1.07 Billion CNY | 18.42% |
| 2014 Q4 | 223.03 Million CNY | -36.77% |
| 2014 Q3 | 352.71 Million CNY | 28.24% |
| 2014 Q1 | 228.04 Million CNY | 5.87% |
| 2013 Q4 | 215.38 Million CNY | -25.56% |
| 2013 FY | 910.99 Million CNY | 23.5% |
| 2013 Q1 | 188.35 Million CNY | -0.33% |
| 2013 Q2 | 217.9 Million CNY | 15.69% |
| 2013 Q3 | 289.34 Million CNY | 32.79% |
| 2012 Q1 | 163.28 Million CNY | -12.1% |
| 2012 Q4 | 188.96 Million CNY | -13.6% |
| 2012 Q3 | 218.71 Million CNY | 31.23% |
| 2012 Q2 | 166.66 Million CNY | 2.07% |
| 2012 FY | 737.63 Million CNY | 1.71% |
| 2011 Q3 | 214.58 Million CNY | 20.16% |
| 2011 Q1 | 146.26 Million CNY | 13.55% |
| 2011 Q2 | 178.58 Million CNY | 22.1% |
| 2011 Q4 | 185.76 Million CNY | -13.43% |
| 2011 FY | 725.19 Million CNY | 48.75% |
| 2010 FY | 487.53 Million CNY | 40.81% |
| 2010 Q2 | 111.2 Million CNY | 12.21% |
| 2010 Q1 | 99.1 Million CNY | 12.02% |
| 2010 Q3 | 148.4 Million CNY | 33.45% |
| 2010 Q4 | 128.81 Million CNY | -13.2% |
| 2009 Q1 | 70.31 Million CNY | 18.61% |
| 2009 FY | 346.24 Million CNY | 42.26% |
| 2009 Q4 | 88.47 Million CNY | -14.61% |
| 2009 Q3 | 103.61 Million CNY | 23.57% |
| 2009 Q2 | 83.84 Million CNY | 19.25% |
| 2008 FY | 243.39 Million CNY | 37.43% |
| 2008 Q3 | 78.48 Million CNY | 0.0% |
| 2008 Q4 | 59.27 Million CNY | -24.47% |
| 2007 FY | 177.1 Million CNY | 79.4% |
| 2006 FY | 98.72 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 6.27 Billion CNY | -64.794% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 4.6 Billion CNY | -124.756% |